FRAXA Biotech Games for Fragile X Research

FRAXA Biotech Games™, a “friendly” competition between greater Boston area biotech companies.

FRAXA Research Foundation

Finding effective treatments and ultimately

A CURE FOR FRAGILE X SYNDROME

FRAXA's Impact to Date

$
0
27,944,500

Direct Investment in Fragile X Research

Current FRAXA Funded Fragile X Research

0
4

ONGOING FRAGILE X CLINICAL TRIALS AND STUDIES

Current Clinical Trials
0
33

TEAMS ACTIVELY RESEARCHING FRAGILE X

Current Research Grants
0
4

GENE THERAPY AND PROTEIN REPLACEMENT STUDIES

Current Studies
0
28

PHARMACEUTICAL AND BIOMEDICAL PARTNERS

0
11

COUNTRIES ARE HOME TO RESEARCH TEAMS

What is Fragile X Syndrome?

Fragile X syndrome (FXS) is the most common inherited cause of autism and intellectual disabilities. It affects 1 in 4,000 boys and 1 in 6,000 girls worldwide.

Fragile X syndrome occurs when a single gene on the X chromosome shuts down. This gene makes a protein needed for normal brain development. In FXS it does not work properly, the protein is not made, and the brain does not develop as it should.

Learn more about Fragile X syndrome

How Does FRAXA Help?

FRAXA’s mission is to find effective treatments and ultimately a cure for Fragile X syndrome. We directly fund research grants and fellowships at top universities around the world. We partner with biomedical and pharmaceutical companies, large and small, to bridge the gap between research discoveries and actual treatments.

Treatments for Fragile X are likely to help people affected by autism, Alzheimer’s, and other brain disorders.

Donate to FRAXA's mission

Latest Fragile X News & Updates

View all News & Updates

FRAXA Welcomes Elle to the Team!

Ellen Skala, known as Elle, has joined FRAXA Research Foundation as Program Coordinator. Elle is excited to work on the FRAXA team and we are excited to have her on board! She has experience in grant writing and personal fundraising campaigns. In her new role as program coordinator, Elle will communicate with FRAXA supporters throughout the country, connecting them to the mission and assisting them in fundraising and awareness-raising activities.
Read more

Deep Molecular Profiling of Fragile X Mouse and Human Cells

FRAXA Research Foundation has awarded $90,000 to Dr. Joel Richter, Principal Investigator, and Dr. Sneha Shah, Postdoctoral Fellow, at the University of Massachusetts Medical School. They are using human induced pluripotent stem (iPS) cells to analyze gene expression in Fragile X syndrome.
Read more

22 Landmarks Lit up Teal for Fragile X Awareness Day

Last year, Niagara Falls was the one and only landmark lit up teal for Fragile X Awareness Day. This year, it was 1 of more than 20! On July 22, to mark Fragile X Awareness Day, buildings, bridges, monuments, and neighborhoods across the land were illuminated in FRAXA’s signature teal. Lighting Up Teal for Fragile X was the result of work of a team of passionate FRAXA volunteers.
Read more

Upcoming Events

View full event calendar
genes & Gems
Saturday, November 16, 2019

Genes & Gems

Renaissance Columbus Hotel, 409 Altair Pkwy, Westerville, OH 43082, USA

No event found!